Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DV.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ES.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.19.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.479NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.437NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.371NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.6.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HU.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KJ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JC.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.625NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HD.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GY.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.109NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.361NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.417NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AM.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.319NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.182NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.430NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.331NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-14127.1South Korea
AY.112.3 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.515NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.287NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.431NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.170NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.506NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.6.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.438.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.188NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.501NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.226NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.546NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.194NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.429.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used